319 related articles for article (PubMed ID: 7585946)
1. A dominant mutation in the Ikaros gene leads to rapid development of leukemia and lymphoma.
Winandy S; Wu P; Georgopoulos K
Cell; 1995 Oct; 83(2):289-99. PubMed ID: 7585946
[TBL] [Abstract][Full Text] [Related]
2. Selective defects in the development of the fetal and adult lymphoid system in mice with an Ikaros null mutation.
Wang JH; Nichogiannopoulou A; Wu L; Sun L; Sharpe AH; Bigby M; Georgopoulos K
Immunity; 1996 Dec; 5(6):537-49. PubMed ID: 8986714
[TBL] [Abstract][Full Text] [Related]
3. The role of the Ikaros gene in lymphocyte development and homeostasis.
Georgopoulos K; Winandy S; Avitahl N
Annu Rev Immunol; 1997; 15():155-76. PubMed ID: 9143685
[TBL] [Abstract][Full Text] [Related]
4. Ikaros null mice display defects in T cell selection and CD4 versus CD8 lineage decisions.
Urban JA; Winandy S
J Immunol; 2004 Oct; 173(7):4470-8. PubMed ID: 15383578
[TBL] [Abstract][Full Text] [Related]
5. Zinc finger-mediated protein interactions modulate Ikaros activity, a molecular control of lymphocyte development.
Sun L; Liu A; Georgopoulos K
EMBO J; 1996 Oct; 15(19):5358-69. PubMed ID: 8895580
[TBL] [Abstract][Full Text] [Related]
6. The Ikaros gene is required for the development of all lymphoid lineages.
Georgopoulos K; Bigby M; Wang JH; Molnar A; Wu P; Winandy S; Sharpe A
Cell; 1994 Oct; 79(1):143-56. PubMed ID: 7923373
[TBL] [Abstract][Full Text] [Related]
7. Expression of dominant-negative Ikaros isoforms in T-cell acute lymphoblastic leukemia.
Sun L; Crotty ML; Sensel M; Sather H; Navara C; Nachman J; Steinherz PG; Gaynon PS; Seibel N; Mao C; Vassilev A; Reaman GH; Uckun FM
Clin Cancer Res; 1999 Aug; 5(8):2112-20. PubMed ID: 10473095
[TBL] [Abstract][Full Text] [Related]
8. Aiolos, a lymphoid restricted transcription factor that interacts with Ikaros to regulate lymphocyte differentiation.
Morgan B; Sun L; Avitahl N; Andrikopoulos K; Ikeda T; Gonzales E; Wu P; Neben S; Georgopoulos K
EMBO J; 1997 Apr; 16(8):2004-13. PubMed ID: 9155026
[TBL] [Abstract][Full Text] [Related]
9. Notch activation is an early and critical event during T-Cell leukemogenesis in Ikaros-deficient mice.
Dumortier A; Jeannet R; Kirstetter P; Kleinmann E; Sellars M; dos Santos NR; Thibault C; Barths J; Ghysdael J; Punt JA; Kastner P; Chan S
Mol Cell Biol; 2006 Jan; 26(1):209-20. PubMed ID: 16354692
[TBL] [Abstract][Full Text] [Related]
10. Ikaros induces quiescence and T-cell differentiation in a leukemia cell line.
Kathrein KL; Lorenz R; Innes AM; Griffiths E; Winandy S
Mol Cell Biol; 2005 Mar; 25(5):1645-54. PubMed ID: 15713624
[TBL] [Abstract][Full Text] [Related]
11. Ikaros regulates Notch target gene expression in developing thymocytes.
Chari S; Winandy S
J Immunol; 2008 Nov; 181(9):6265-74. PubMed ID: 18941217
[TBL] [Abstract][Full Text] [Related]
12. Helios, a novel dimerization partner of Ikaros expressed in the earliest hematopoietic progenitors.
Kelley CM; Ikeda T; Koipally J; Avitahl N; Wu L; Georgopoulos K; Morgan BA
Curr Biol; 1998 Apr; 8(9):508-15. PubMed ID: 9560339
[TBL] [Abstract][Full Text] [Related]
13. Cell-autonomous defects in dendritic cell populations of Ikaros mutant mice point to a developmental relationship with the lymphoid lineage.
Wu L; Nichogiannopoulou A; Shortman K; Georgopoulos K
Immunity; 1997 Oct; 7(4):483-92. PubMed ID: 9354469
[TBL] [Abstract][Full Text] [Related]
14. Activating Notch1 mutations are an early event in T-cell malignancy of Ikaros point mutant Plastic/+ mice.
Mantha S; Ward M; McCafferty J; Herron A; Palomero T; Ferrando A; Bank A; Richardson C
Leuk Res; 2007 Mar; 31(3):321-7. PubMed ID: 16870249
[TBL] [Abstract][Full Text] [Related]
15. Pre-T cell receptor (TCR) and TCR-controlled checkpoints in T cell differentiation are set by Ikaros.
Winandy S; Wu L; Wang JH; Georgopoulos K
J Exp Med; 1999 Oct; 190(8):1039-48. PubMed ID: 10523602
[TBL] [Abstract][Full Text] [Related]
16. Expression of aberrantly spliced oncogenic ikaros isoforms in childhood acute lymphoblastic leukemia.
Sun L; Goodman PA; Wood CM; Crotty ML; Sensel M; Sather H; Navara C; Nachman J; Steinherz PG; Gaynon PS; Seibel N; Vassilev A; Juran BD; Reaman GH; Uckun FM
J Clin Oncol; 1999 Dec; 17(12):3753-66. PubMed ID: 10577847
[TBL] [Abstract][Full Text] [Related]
17. Expression of dominant-negative and mutant isoforms of the antileukemic transcription factor Ikaros in infant acute lymphoblastic leukemia.
Sun L; Heerema N; Crotty L; Wu X; Navara C; Vassilev A; Sensel M; Reaman GH; Uckun FM
Proc Natl Acad Sci U S A; 1999 Jan; 96(2):680-5. PubMed ID: 9892693
[TBL] [Abstract][Full Text] [Related]
18. Protein phosphatase 1 (PP1) and Casein Kinase II (CK2) regulate Ikaros-mediated repression of TdT in thymocytes and T-cell leukemia.
Wang H; Song C; Gurel Z; Song N; Ma J; Ouyang H; Lai L; Payne KJ; Dovat S
Pediatr Blood Cancer; 2014 Dec; 61(12):2230-5. PubMed ID: 25214003
[TBL] [Abstract][Full Text] [Related]
19. Ikaros, an early lymphoid-specific transcription factor and a putative mediator for T cell commitment.
Georgopoulos K; Moore DD; Derfler B
Science; 1992 Oct; 258(5083):808-12. PubMed ID: 1439790
[TBL] [Abstract][Full Text] [Related]
20. Defects in hemopoietic stem cell activity in Ikaros mutant mice.
Nichogiannopoulou A; Trevisan M; Neben S; Friedrich C; Georgopoulos K
J Exp Med; 1999 Nov; 190(9):1201-14. PubMed ID: 10544193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
